Clinical Trial Update: Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating autologous bone marrow-derived stem cell transplantation for efficacy in Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Autologous bone marrow-derived stem cell transplantation

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED